Further studies are required to investigate the utility of mTOR pathway inhibitors in the treatment of PXA, though it has proven efficacious in the treatment of sub-ependymal giant cell astrocytomas, another rare pediatric brain tumor[36]. The gene discussed is MTOR; the disease is astrocytoma (excluding glioblastoma).